DDR2 and breast cancer: We first immunolocalized DDR2 and collagen type I in 224 breast cancer specimens, and the immunoreactivity of DDR2 was observed in the cytoplasm of the carcinoma cells (Figure 1A), while it was quite slight in normal breast epithelium (Figure 1B).